Summit Therapeutics Inc. (SMMT)
NASDAQ·Healthcare·Biotechnology
$17.48
+2.85%
Mkt Cap $14.04B
Analyst Ratings
Buy
5
Hold
5
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
Implied Upside
+11.6%
Consensus $19.50 vs current $17.48
NASDAQ·Healthcare·Biotechnology
$17.48
+2.85%
Mkt Cap $14.04B
Buy
5
Hold
5
Sell
0
Price Target (20 analysts)
$19.50
Range $16.00 – $23.00
+11.6%
Consensus $19.50 vs current $17.48